381 related articles for article (PubMed ID: 18758480)
1. Notch tumor suppressor function.
Dotto GP
Oncogene; 2008 Sep; 27(38):5115-23. PubMed ID: 18758480
[TBL] [Abstract][Full Text] [Related]
2. The role of Notch signaling in human cervical cancer: implications for solid tumors.
Maliekal TT; Bajaj J; Giri V; Subramanyam D; Krishna S
Oncogene; 2008 Sep; 27(38):5110-4. PubMed ID: 18758479
[TBL] [Abstract][Full Text] [Related]
3. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases.
Lefort K; Mandinova A; Ostano P; Kolev V; Calpini V; Kolfschoten I; Devgan V; Lieb J; Raffoul W; Hohl D; Neel V; Garlick J; Chiorino G; Dotto GP
Genes Dev; 2007 Mar; 21(5):562-77. PubMed ID: 17344417
[TBL] [Abstract][Full Text] [Related]
4. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation.
Nguyen BC; Lefort K; Mandinova A; Antonini D; Devgan V; Della Gatta G; Koster MI; Zhang Z; Wang J; Tommasi di Vignano A; Kitajewski J; Chiorino G; Roop DR; Missero C; Dotto GP
Genes Dev; 2006 Apr; 20(8):1028-42. PubMed ID: 16618808
[TBL] [Abstract][Full Text] [Related]
5. Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression.
Lefort K; Dotto GP
Semin Cancer Biol; 2004 Oct; 14(5):374-86. PubMed ID: 15288263
[TBL] [Abstract][Full Text] [Related]
6. DeltaNp63alpha repression of the Notch1 gene supports the proliferative capacity of normal human keratinocytes and cervical cancer cells.
Yugawa T; Narisawa-Saito M; Yoshimatsu Y; Haga K; Ohno S; Egawa N; Fujita M; Kiyono T
Cancer Res; 2010 May; 70(10):4034-44. PubMed ID: 20442293
[TBL] [Abstract][Full Text] [Related]
7. Canonical
Herrick DB; Guo Z; Jang W; Schnittke N; Schwob JE
J Neurosci; 2018 May; 38(21):5022-5037. PubMed ID: 29739871
[TBL] [Abstract][Full Text] [Related]
8. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
[TBL] [Abstract][Full Text] [Related]
9. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
10. It's T-ALL about Notch.
Demarest RM; Ratti F; Capobianco AJ
Oncogene; 2008 Sep; 27(38):5082-91. PubMed ID: 18758476
[TBL] [Abstract][Full Text] [Related]
11. Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways.
Talora C; Cialfi S; Segatto O; Morrone S; Kim Choi J; Frati L; Paolo Dotto G; Gulino A; Screpanti I
Exp Cell Res; 2005 May; 305(2):343-54. PubMed ID: 15817159
[TBL] [Abstract][Full Text] [Related]
12. Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways.
McElhinny AS; Li JL; Wu L
Oncogene; 2008 Sep; 27(38):5138-47. PubMed ID: 18758483
[TBL] [Abstract][Full Text] [Related]
13. The FoxO3a gene is a key negative target of canonical Notch signalling in the keratinocyte UVB response.
Mandinova A; Lefort K; Tommasi di Vignano A; Stonely W; Ostano P; Chiorino G; Iwaki H; Nakanishi J; Dotto GP
EMBO J; 2008 Apr; 27(8):1243-54. PubMed ID: 18388864
[TBL] [Abstract][Full Text] [Related]
14. A new tumor suppressor role for the Notch pathway in bladder cancer.
Rampias T; Vgenopoulou P; Avgeris M; Polyzos A; Stravodimos K; Valavanis C; Scorilas A; Klinakis A
Nat Med; 2014 Oct; 20(10):1199-205. PubMed ID: 25194568
[TBL] [Abstract][Full Text] [Related]
15. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation.
Talora C; Sgroi DC; Crum CP; Dotto GP
Genes Dev; 2002 Sep; 16(17):2252-63. PubMed ID: 12208848
[TBL] [Abstract][Full Text] [Related]
16. Notch1 Activation or Loss Promotes HPV-Induced Oral Tumorigenesis.
Zhong R; Bao R; Faber PW; Bindokas VP; Bechill J; Lingen MW; Spiotto MT
Cancer Res; 2015 Sep; 75(18):3958-3969. PubMed ID: 26294213
[TBL] [Abstract][Full Text] [Related]
17. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk of Notch with p53 and p63 in cancer growth control.
Dotto GP
Nat Rev Cancer; 2009 Aug; 9(8):587-95. PubMed ID: 19609265
[TBL] [Abstract][Full Text] [Related]
19. The double-edged sword of Notch signaling in cancer.
South AP; Cho RJ; Aster JC
Semin Cell Dev Biol; 2012 Jun; 23(4):458-64. PubMed ID: 22309843
[TBL] [Abstract][Full Text] [Related]
20. Notch as a tumour suppressor.
Nowell CS; Radtke F
Nat Rev Cancer; 2017 Mar; 17(3):145-159. PubMed ID: 28154375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
